The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study.

Source:http://linkedlifedata.com/resource/pubmed/id/17442658

Download in:

View as

General Info

PMID
17442658